List of Tables
Table 1: Number of Products under Development for Graft Versus Host Disease (GVHD)
Table 2: Number of Products under Development by Companies, Graft Versus Host Disease (GVHD)
Table 3: Number of Products under Development by Universities/Institutes, Graft Versus Host Disease (GVHD)
Table 4: Products under Development by Companies, Graft Versus Host Disease (GVHD)
Table 5: Products under Development by Universities/Institutes, Graft Versus Host Disease (GVHD)
Table 6: Number of Products under Development for Liver Transplant Rejection
Table 7: Number of Products under Development by Companies, Liver Transplant Rejection
Table 8: Number of Products under Development by Universities/Institutes, Liver Transplant Rejection
Table 9: Products under Development by Companies, Liver Transplant Rejection
Table 10: Products under Development by Universities/Institutes, Liver Transplant Rejection
Table 11: Number of Products under Development for Kidney Transplant Rejection
Table 12: Number of Products under Development by Companies, Kidney Transplant Rejection
Table 13: Number of Products under Development by Universities/Institutes, Kidney Transplant Rejection
Table 14: Products under Development by Companies, Kidney Transplant Rejection
Table 15: Products under Development by Universities/Institutes, Kidney Transplant Rejection
Table 16: Number of Products under Development for Lung Transplant Rejection
Table 17: Number of Products under Development by Companies, Lung Transplant Rejection
Table 18: Products under Development by Companies, Lung Transplant Rejection
Table 19: Number of Products by Stage and Target, Graft Versus Host Disease (GVHD)
Table 20: Number of Products by Stage and Mechanism of Action, Graft Versus Host Disease (GVHD)
Table 21: Number of Products by Stage and Route of Administration, Graft Versus Host Disease (GVHD)
Table 22: Number of Products by Stage and Molecule Type, Graft Versus Host Disease (GVHD)
Table 23: Number of Products by Stage and Target, Liver Transplant Rejection
Table 24: Number of Products by Stage and Mechanism of Action, Liver Transplant Rejection
Table 25: Number of Products by Stage and Route of Administration, Liver Transplant Rejection
Table 26: Number of Products by Stage and Molecule Type, Liver Transplant Rejection
Table 27: Number of Products by Stage and Target, Kidney Transplant Rejection
Table 28: Number of Products by Stage and Mechanism of Action, Kidney Transplant Rejection
Table 29: Number of Products by Stage and Route of Administration, Kidney Transplant Rejection
Table 30: Number of Products by Stage and Molecule Type, Kidney Transplant Rejection
Table 31: Number of Products by Stage and Target, Lung Transplant Rejection
Table 32: Number of Products by Stage and Mechanism of Action, Lung Transplant Rejection
Table 33: Number of Products by Stage and Route of Administration, Lung Transplant Rejection
Table 34: Number of Products by Stage and Molecule Type, Lung Transplant Rejection
Table 35: Graft Versus Host Disease (GVHD) – Pipeline by AbbVie Inc
Table 36: Graft Versus Host Disease (GVHD) – Pipeline by AbGenomics International Inc
Table 37: Graft Versus Host Disease (GVHD) – Pipeline by Amgen Inc
Table 38: Graft Versus Host Disease (GVHD) – Pipeline by AnaptysBio Inc
Table 39: Graft Versus Host Disease (GVHD) – Pipeline by apceth Biopharma GmbH
Table 40: Graft Versus Host Disease (GVHD) – Pipeline by Aptevo Therapeutics Inc
Table 41: Graft Versus Host Disease (GVHD) – Pipeline by Athersys Inc
Table 42: Graft Versus Host Disease (GVHD) – Pipeline by Bellicum Pharmaceuticals Inc
Table 43: Graft Versus Host Disease (GVHD) – Pipeline by Biogen Inc
Table 44: Graft Versus Host Disease (GVHD) – Pipeline by Bristol-Myers Squibb Co
Table 45: Graft Versus Host Disease (GVHD) – Pipeline by Capricor Therapeutics Inc
Table 46: Graft Versus Host Disease (GVHD) – Pipeline by Cell2B Advanced Therapeutics SA
Table 47: Graft Versus Host Disease (GVHD) – Pipeline by Cellect Biotechnology Ltd
Table 48: Graft Versus Host Disease (GVHD) – Pipeline by Cellective BioTherapy Inc
Table 49: Graft Versus Host Disease (GVHD) – Pipeline by CSL Ltd
Table 50: Graft Versus Host Disease (GVHD) – Pipeline by Cynata Therapeutics Ltd
Table 51: Graft Versus Host Disease (GVHD) – Pipeline by Cytodyn Inc
Table 52: Graft Versus Host Disease (GVHD) – Pipeline by Elsalys Biotech SA
Table 53: Graft Versus Host Disease (GVHD) – Pipeline by enGene Inc
Table 54: Graft Versus Host Disease (GVHD) – Pipeline by Enlivex Therapeutics Ltd
Table 55: Graft Versus Host Disease (GVHD) – Pipeline by F. Hoffmann-La Roche Ltd
Table 56: Graft Versus Host Disease (GVHD) – Pipeline by Fate Therapeutics Inc
Table 57: Graft Versus Host Disease (GVHD) – Pipeline by Generon (Shanghai) Corp Ltd
Table 58: Graft Versus Host Disease (GVHD) – Pipeline by GlaxoSmithKline Plc
Table 59: Graft Versus Host Disease (GVHD) – Pipeline by Incyte Corp
Table 60: Graft Versus Host Disease (GVHD) – Pipeline by Inspyr Therapeutics Inc
Table 61: Graft Versus Host Disease (GVHD) – Pipeline by Jazz Pharmaceuticals Plc
Table 62: Graft Versus Host Disease (GVHD) – Pipeline by Johnson & Johnson
Table 63: Graft Versus Host Disease (GVHD) – Pipeline by Kadmon Corp LLC
Table 64: Graft Versus Host Disease (GVHD) – Pipeline by Kamada Ltd
Table 65: Graft Versus Host Disease (GVHD) – Pipeline by Kiadis Pharma NV
Table 66: Graft Versus Host Disease (GVHD) – Pipeline by Kymab Ltd
Table 67: Graft Versus Host Disease (GVHD) – Pipeline by LG Chem Ltd
Table 68: Graft Versus Host Disease (GVHD) – Pipeline by MaaT Pharma
Table 69: Graft Versus Host Disease (GVHD) – Pipeline by Magenta Therapeutics Inc
Table 70: Graft Versus Host Disease (GVHD) – Pipeline by MallInckrodt Plc
Table 71: Graft Versus Host Disease (GVHD) – Pipeline by Medicenna Therapeutics Corp
Table 72: Graft Versus Host Disease (GVHD) – Pipeline by Mesoblast Ltd
Table 73: Graft Versus Host Disease (GVHD) – Pipeline by Millennium Pharmaceuticals Inc
Table 74: Graft Versus Host Disease (GVHD) – Pipeline by Novartis AG
Table 75: Graft Versus Host Disease (GVHD) – Pipeline by OncoImmune Inc
Table 76: Graft Versus Host Disease (GVHD) – Pipeline by Pfizer Inc
Table 77: Graft Versus Host Disease (GVHD) – Pipeline by Pharmicell Co Ltd
Table 78: Graft Versus Host Disease (GVHD) – Pipeline by Pluristem Therapeutics Inc
Table 79: Graft Versus Host Disease (GVHD) – Pipeline by REGiMMUNE Corp
Table 80: Graft Versus Host Disease (GVHD) – Pipeline by Sanofi
Table 81: Graft Versus Host Disease (GVHD) – Pipeline by Seattle Genetics Inc
Table 82: Graft Versus Host Disease (GVHD) – Pipeline by Seres Therapeutics Inc
Table 83: Graft Versus Host Disease (GVHD) – Pipeline by Sublimity Therapeutics Ltd
Table 84: Graft Versus Host Disease (GVHD) – Pipeline by Syndax Pharmaceuticals Inc
Table 85: Graft Versus Host Disease (GVHD) – Pipeline by Takeda Pharmaceutical Co Ltd
Table 86: Graft Versus Host Disease (GVHD) – Pipeline by Targazyme Inc
Table 87: Graft Versus Host Disease (GVHD) – Pipeline by TC BioPharm Ltd
Table 88: Graft Versus Host Disease (GVHD) – Pipeline by TxCell SA
Table 89: Graft Versus Host Disease (GVHD) – Pipeline by United BioPharma Inc
Table 90: Graft Versus Host Disease (GVHD) – Pipeline by Vault Pharma Inc
Table 91: Graft Versus Host Disease (GVHD) – Pipeline by VBI Vaccines Inc
Table 92: Graft Versus Host Disease (GVHD) – Pipeline by Visterra Inc
Table 93: Graft Versus Host Disease (GVHD) – Pipeline by Xenikos BV
Table 94: Graft Versus Host Disease (GVHD) – Pipeline by XL-protein GmbH
Table 95: Graft Versus Host Disease (GVHD) – Pipeline by Zai Lab Ltd
Table 96: Liver Transplant Rejection – Pipeline by Alexion Pharmaceuticals Inc
Table 97: Liver Transplant Rejection – Pipeline by Dompe Farmaceutici SpA
Table 98: Liver Transplant Rejection – Pipeline by Novartis AG
Table 99: Liver Transplant Rejection – Pipeline by RedHill Biopharma Ltd
Table 100: Liver Transplant Rejection – Pipeline by Veloxis Pharmaceuticals A/S
Table 101: Kidney Transplant Rejection – Pipeline by Amgen Inc
Table 102: Kidney Transplant Rejection – Pipeline by Angion Biomedica Corp
Table 103: Kidney Transplant Rejection – Pipeline by Astellas Pharma Inc
Table 104: Kidney Transplant Rejection – Pipeline by Balmes Transplantation SAS
Table 105: Kidney Transplant Rejection – Pipeline by Bioverativ Inc
Table 106: Kidney Transplant Rejection – Pipeline by Catalyst Biosciences Inc
Table 107: Kidney Transplant Rejection – Pipeline by CSL Ltd
Table 108: Kidney Transplant Rejection – Pipeline by Gilead Sciences Inc
Table 109: Kidney Transplant Rejection – Pipeline by Hansa Medical AB
Table 110: Kidney Transplant Rejection – Pipeline by Idogen AB
Table 111: Kidney Transplant Rejection – Pipeline by ITB-Med AB
Table 112: Kidney Transplant Rejection – Pipeline by Johnson & Johnson
Table 113: Kidney Transplant Rejection – Pipeline by Kyowa Hakko Kirin Co Ltd
Table 114: Kidney Transplant Rejection – Pipeline by Noorik Biopharmaceuticals AG
Table 115: Kidney Transplant Rejection – Pipeline by Novartis AG
Table 116: Kidney Transplant Rejection – Pipeline by Opsona Therapeutics Ltd
Table 117: Kidney Transplant Rejection – Pipeline by Pharmicell Co Ltd
Table 118: Kidney Transplant Rejection – Pipeline by Pharming Group NV
Table 119: Kidney Transplant Rejection – Pipeline by Prolong Pharmaceuticals LLC
Table 120: Kidney Transplant Rejection – Pipeline by Quark Pharmaceuticals Inc
Table 121: Kidney Transplant Rejection – Pipeline by Shire Plc
Table 122: Kidney Transplant Rejection – Pipeline by TolerogenixX GmbH
Table 123: Kidney Transplant Rejection – Pipeline by TxCell SA
Table 124: Lung Transplant Rejection – Pipeline by Amgen Inc
Table 125: Lung Transplant Rejection – Pipeline by Kamada Ltd
Table 126: Lung Transplant Rejection – Pipeline by MimeTech Srl
Table 127: Lung Transplant Rejection – Pipeline by Novartis AG
Table 128: Lung Transplant Rejection – Pipeline by Quark Pharmaceuticals Inc
Table 129: Lung Transplant Rejection – Pipeline by TxCell SA
Table 130: Graft Versus Host Disease (GVHD) – Dormant Projects
Table 131: Liver Transplant Rejection – Dormant Projects
Table 132: Kidney Transplant Rejection – Dormant Projects
Table 133: Lung Transplant Rejection – Dormant Projects
Table 134: Graft Versus Host Disease (GVHD) – Discontinued Products
Table 135: Liver Transplant Rejection – Discontinued Products
Table 136: Kidney Transplant Rejection – Discontinued Products